Alnylam's Brendan Martin joined the pharmaphorum podcast for episode 23 to talk about his company's work in gene-silencing and how it could offer a route to target the current coronavirus p
Novartis’ Steven Baert joined the pharmaphorum podcast for episode 22 to discuss how COVID-19 will change the face of company culture, now and in the future.
Harvard University launched LabXchange in January and the free science education platform acquired new resonance during the COVID-19 lockdowns that saw millions of students around the world
The COVID-19 pandemic has forced significant changes on the pharmaceutical industry as companies scramble to protect employees, ensure business continuity and maintain patient access to med
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.